{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:22:13Z","timestamp":1791336133369,"version":"4.3.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7544","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/nature14332","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T11:03:11Z","timestamp":1426762991000},"page":"472-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":330,"title":["Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease"],"prefix":"10.1038","volume":"519","author":[{"given":"Dong I.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshuo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazha","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Holewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hyun","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Rainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djahida","family":"Bedja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Ranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Dostmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth B.","family":"Margulies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Van Eyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiki","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,18]]},"reference":[{"key":"BFnature14332_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nm1175","volume":"11","author":"E Takimoto","year":"2005","unstructured":"Takimoto, E. et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nature Med. 11, 214\u2013222 (2005)","journal-title":"Nature Med."},{"key":"BFnature14332_CR2","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2011.09.086","volume":"59","author":"RC Kukreja","year":"2012","unstructured":"Kukreja, R. C., Salloum, F. N. & Das, A. Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. J. Am. Coll. Cardiol. 59, 1921\u20131927 (2012)","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnature14332_CR3","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1091\/mbc.e03-12-0890","volume":"15","author":"F Mullershausen","year":"2004","unstructured":"Mullershausen, F., Russwurm, M., Koesling, D. & Friebe, A. In vivo reconstitution of the negative feedback in nitric oxide\/cGMP signaling: role of phosphodiesterase type 5 phosphorylation. Mol. Biol. Cell 15, 4023\u20134030 (2004)","journal-title":"Mol. Biol. Cell"},{"key":"BFnature14332_CR4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1161\/CIRCULATIONAHA.105.599241","volume":"113","author":"LR Castro","year":"2006","unstructured":"Castro, L. R., Verde, I., Cooper, D. M. & Fischmeister, R. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Circulation 113, 2221\u20132228 (2006)","journal-title":"Circulation"},{"key":"BFnature14332_CR5","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1161\/CIRCULATIONAHA.106.643536","volume":"115","author":"E Takimoto","year":"2007","unstructured":"Takimoto, E. et al. Compartmentalization of cardiac \u03b2-adrenergic inotropy modulation by phosphodiesterase type 5. Circulation 115, 2159\u20132167 (2007)","journal-title":"Circulation"},{"key":"BFnature14332_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1089\/ars.2012.4824","volume":"18","author":"R Carnicer","year":"2013","unstructured":"Carnicer, R., Crabtree, M. J., Sivakumaran, V., Casadei, B. & Kass, D. A. Nitric oxide synthases in heart failure. Antioxid. Redox Signal. 18, 1078\u20131099 (2013)","journal-title":"Antioxid. Redox Signal."},{"key":"BFnature14332_CR7","doi-asserted-by":"publisher","first-page":"15553","DOI":"10.1074\/jbc.273.25.15553","volume":"273","author":"SH Soderling","year":"1998","unstructured":"Soderling, S. H., Bayuga, S. J. & Beavo, J. A. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J. Biol. Chem. 273, 15553\u201315558 (1998)","journal-title":"J. Biol. Chem."},{"key":"BFnature14332_CR8","doi-asserted-by":"publisher","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","volume":"273","author":"DA Fisher","year":"1998","unstructured":"Fisher, D. A., Smith, J. F., Pillar, J. S., St Denis, S. H. & Cheng, J. B. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J. Biol. Chem. 273, 15559\u201315564 (1998)","journal-title":"J. Biol. Chem."},{"key":"BFnature14332_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","volume":"76","author":"M Conti","year":"2007","unstructured":"Conti, M. & Beavo, J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 76, 481\u2013511 (2007)","journal-title":"Annu. Rev. Biochem."},{"key":"BFnature14332_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1124\/jpet.111.191353","volume":"341","author":"RJ Kleiman","year":"2012","unstructured":"Kleiman, R. J. et al. Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo. J. Pharmacol. Exp. Ther. 341, 396\u2013409 (2012)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnature14332_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2174\/1381612820666140826114601","volume":"21","author":"PR Heckman","year":"2015","unstructured":"Heckman, P. R., Wouters, C. & Prickaerts, J. Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer\u2019s disease: a translational overview. Curr. Pharm. Des. 21, 317\u2013331 (2015)","journal-title":"Curr. Pharm. Des."},{"key":"BFnature14332_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","volume":"115","author":"K Sharma","year":"2014","unstructured":"Sharma, K. & Kass, D. A. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ. Res. 115, 79\u201396 (2014)","journal-title":"Circ. Res."},{"key":"BFnature14332_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1073\/pnas.0710387105","volume":"105","author":"LW Nausch","year":"2008","unstructured":"Nausch, L. W., Ledoux, J., Bonev, A. D., Nelson, M. T. & Dostmann, W. R. Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensors. Proc. Natl Acad. Sci. USA 105, 365\u2013370 (2008)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature14332_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/01.RES.0000232322.06633.d3","volume":"99","author":"G Singh","year":"2006","unstructured":"Singh, G., Kuc, R. E., Maguire, J. J., Fidock, M. & Davenport, A. P. Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure. Circ. Res. 99, 183\u2013190 (2006)","journal-title":"Circ. Res."},{"key":"BFnature14332_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.devcel.2012.08.017","volume":"23","author":"J Davis","year":"2012","unstructured":"Davis, J., Burr, A. R., Davis, G. F., Birnbaumer, L. & Molkentin, J. D. A. TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev. Cell 23, 705\u2013715 (2012)","journal-title":"Dev. Cell"},{"key":"BFnature14332_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.yjmcc.2009.11.015","volume":"48","author":"N Koitabashi","year":"2010","unstructured":"Koitabashi, N. et al. Cyclic GMP\/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation: novel mechanism of cardiac stress modulation by PDE5 inhibition. J. Mol. Cell. Cardiol. 48, 713\u2013724 (2010)","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnature14332_CR17","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/CIRCRESAHA.109.208314","volume":"106","author":"H Kinoshita","year":"2010","unstructured":"Kinoshita, H. et al. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart. Circ. Res. 106, 1849\u20131860 (2010)","journal-title":"Circ. Res."},{"key":"BFnature14332_CR18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1161\/CIRCRESAHA.110.230698","volume":"108","author":"A Stangherlin","year":"2011","unstructured":"Stangherlin, A. et al. cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes. Circ. Res. 108, 929\u2013939 (2011)","journal-title":"Circ. Res."},{"key":"BFnature14332_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2741\/1616","volume":"10","author":"RB Pilz","year":"2005","unstructured":"Pilz, R. B. & Broderick, K. E. Role of cyclic GMP in gene regulation. Front. Biosci. 10, 1239\u20131268 (2005)","journal-title":"Front. Biosci."},{"key":"BFnature14332_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/01.RES.0000215985.18538.c4","volume":"98","author":"T Oka","year":"2006","unstructured":"Oka, T. et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 98, 837\u2013845 (2006)","journal-title":"Circ. Res."},{"key":"BFnature14332_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrd4228","volume":"13","author":"DH Maurice","year":"2014","unstructured":"Maurice, D. H. et al. Advances in targeting cyclic nucleotide phosphodiesterases. Nature Rev. Drug Discov. 13, 290\u2013314 (2014)","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnature14332_CR22","doi-asserted-by":"publisher","first-page":"e000536","DOI":"10.1161\/JAHA.113.000536","volume":"2","author":"SJ Greene","year":"2013","unstructured":"Greene, S. J. et al. The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. J. Am Heart Assoc. 2, e000536 (2013)","journal-title":"J. Am Heart Assoc."},{"key":"BFnature14332_CR23","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jama.2013.2024","volume":"309","author":"MM Redfield","year":"2013","unstructured":"Redfield, M. M. et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. J. Am. Med. Assoc. 309, 1268\u20131277 (2013)","journal-title":"J. Am. Med. Assoc."},{"key":"BFnature14332_CR24","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","volume":"126","author":"L van Heerebeek","year":"2012","unstructured":"van Heerebeek, L. et al. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 126, 830\u2013839 (2012)","journal-title":"Circulation"},{"key":"BFnature14332_CR25","doi-asserted-by":"crossref","unstructured":"McMurray, J. J. et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N. Engl. J. Med. 993\u20131004 (2014)","DOI":"10.1056\/NEJMoa1409077"},{"key":"BFnature14332_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1139\/y11-048","volume":"89","author":"R Zakeri","year":"2011","unstructured":"Zakeri, R. & Burnett, J. C. Designer natriuretic peptides: a vision for the future of heart failure therapeutics. Can. J. Physiol. Pharmacol. 89, 593\u2013601 (2011)","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"BFnature14332_CR27","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1073\/pnas.1308963111","volume":"111","author":"K Seo","year":"2014","unstructured":"Seo, K. et al. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy. Proc. Natl Acad. Sci. USA 111, 1551\u20131556 (2014)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature14332_CR28","doi-asserted-by":"publisher","first-page":"9045","DOI":"10.1021\/jm3007799","volume":"55","author":"PR Verhoest","year":"2012","unstructured":"Verhoest, P. R. et al. Design and discovery of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyr an-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a selective brain penetrant PDE9A inhibitor for the treatment of cognitive disorders. J. Med. Chem. 55, 9045\u20139054 (2012)","journal-title":"J. Med. Chem."},{"key":"BFnature14332_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature07060","volume":"454","author":"B Zhou","year":"2008","unstructured":"Zhou, B. et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454, 109\u2013113 (2008)","journal-title":"Nature"},{"key":"BFnature14332_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1172\/JCI69253","volume":"124","author":"JA Kirk","year":"2014","unstructured":"Kirk, J. A. et al. Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3beta. J. Clin. Invest. 124, 129\u2013139 (2014)","journal-title":"J. Clin. Invest."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature14332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature14332","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature14332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:30:11Z","timestamp":1684420211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature14332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":30,"journal-issue":{"issue":"7544","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFnature14332"],"URL":"https:\/\/doi.org\/10.1038\/nature14332","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725402305.793505584","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"26 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The received date year was corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}